Will gemcitabine monotherapy be dethroned as the adjuvant chemotherapy in pancreatic adenocarcinoma?. (February 2017)

Record Type:: Journal Article
Title:: Will gemcitabine monotherapy be dethroned as the adjuvant chemotherapy in pancreatic adenocarcinoma?. (February 2017)
Main Title:: Will gemcitabine monotherapy be dethroned as the adjuvant chemotherapy in pancreatic adenocarcinoma?
Authors:: Kourie, Hampig Raphael
Gharios, Joseph
Kattan, Joseph
Abstract:
Is Part Of:: Future oncology. Volume 13:Number 3(2017)
Journal:: Future oncology
Issue:: Volume 13:Number 3(2017)
Issue Display:: Volume 13, Issue 3 (2017)
Year:: 2017
Volume:: 13
Issue:: 3
Issue Sort Value:: 2017-0013-0003-0000
Page Start:: 197
Page End:: 199
Publication Date:: 2017-02
Subjects:: capecitabine -- gemcitabine -- pancreatic adenocarcinoma
Oncology -- Periodicals
616.99405
Journal URLs:: http://www.futuremedicine.com/loi/fon ↗
http://www.futuremedicine.com/ ↗
DOI:: 10.2217/fon-2016-0316 ↗
Languages:: English
ISSNs:: 1479-6694
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 4060.610420
British Library DSC - BLDSS-3PM
British Library HMNTS - Digital store
British Library HMNTS - ELD Digital store
Ingest File:: 20622.xml